New bipolar disorder research highlights a wearable lithium sensor, how mood stabilizers affect thinking, and fathers’ ...
Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE) Bank of America Global Healthcare Conference 2025 September 23, 2025 6:35 AM ...
Aphaia’s lead formulation orchestrates a comprehensive hormonal response from nutrient-sensing cells with potential to modify the course of obesity and associated metabolic diseases.It is currently ...
Bristol Myers Squibb Announces Phase 3 EXCALIBER-RRMM Study Evaluating Iberdomide in Combination with Standard Therapies ...
The science community has pushed back at the latest claims that acetaminophen (aka paracetamol) is a key factor in the ...
MedPage Today on MSN
Daylight Saving and Obesity; Serious CGM App Recall; AACE's Strategic Plan
The FDA said Dexcom issued a correction for certain continuous glucose monitor apps due to a software design error that ...
As a person firmly ensconced in middle age — 57 percent of the way through life, to be precise, if government actuarial tables hold — I have begun to notice certain things not working quite as well as ...
Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback